CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Romiplostim

Last Updated: September 29, 2009
Result type: Reports
Project Number: SR0179-000
Product Line: Reimbursement Review

Generic Name: Romiplostim

Brand Name: Nplate

Manufacturer: Amgen Canada Inc.

Therapeutic Area: Chronic immune (idiopathic) thrombocytopenic purpura (ITP)

Indications: Chronic immune (idiopathic) thrombocytopenic purpura (ITP)

Submission Type: Initial

Project Status: Complete

Date Recommendation Issued: May 27, 2010

Recommendation Type: Do not list